Back to search

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

Data up to Jan 2025

Published1998
Citations164
References29

Total Citations Per Year

Abstract

References (29)

The Biology and Clinical Uses of Blood Stem Cells

1997 • 729 citations

Factors that influence collection and engraftment of autologous peripheral-blood stem cells.

1995 • 659 citations

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1996 • 633 citations

An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy

1995 • 625 citations

Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma

1994 • 484 citations

Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants.

1992 • 427 citations

Autologous progenitor cell transplantation: prior exposure to stem cell- toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts

1995 • 235 citations

High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation

1998 • 186 citations

Hematopoietic growth factors and human megakaryocyte differentiation.

1992 • 172 citations

Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma.

1997 • 147 citations

Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma.

1996 • 133 citations

Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.

1998 • 124 citations

Factors influencing collection of peripheral blood progenitor cells following high‐dose cyclophosphamide and granulocyte colony‐stimulating factor in patients with multiple myeloma

1997 • 112 citations

Peripheral Blood Stem Cell Mobilization by Chemotherapy With and Without Recombinant Human Granulocyte Colony-Stimulating Factor

1992 • 105 citations

Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors

1992 • 103 citations

Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.

1995 • 94 citations

Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim

1998 • 90 citations

Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

1997 • 90 citations

Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells

1992 • 83 citations

Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system

1997 • 80 citations

Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections

1996 • 74 citations

Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor.

1997 • 69 citations

Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte‐colony‐ stimulating factor: an analysis of 497 patients

1997 • 62 citations

Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate‐dose cyclophosphamide

1997 • 61 citations

Hematopoietic precursor cell transplants in Europe: activity in 1994. Report from the European Group for Blood and Marrow Transplantation (EBMT).

1996 • 53 citations

Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest.

1992 • 51 citations

Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).

1993 • 49 citations

A comparison of peripheral blood stem cell mobilisation after chemotherapy with cyclophosphamide as a single agent in doses of 4 g/m2 or 7 g/m2 in patients with advanced cancer

1992 • 34 citations

Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy

1994 • 16 citations

Cited By (0)

No citing papers found in database

Factors associated with successful mobilization of peripheral blood progenitor cells in… (1998) – British Journal of Haematology | Metascience Observatory Explorer